TITLE

Coronary Artery Calcium Screening in Persons with Metabolic Syndrome and Diabetes: Implications for Prevention

AUTHOR(S)
Tehrani, David M.; Malik, Shaista; Wong, Nathan D.
PUB. DATE
June 2013
SOURCE
Metabolic Syndrome & Related Disorders;Jun2013, Vol. 11 Issue 3, p143
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Diabetes and metabolic syndrome are major risk factors for coronary heart disease (CHD). Many patients suffering CHD events are not adequately identified by traditional risk assessment, suggesting the need for early detection of subclinical CHD to identify those at highest risk. Coronary artery calcium (CAC) screening has added utility in categorizing patients with intermediate and high risk of CHD events, and a growing body of evidence suggests its use for CHD risk assessment in persons with metabolic syndrome and diabetes mellitus. These studies demonstrate the presence and extent of CAC to be greater in those with these conditions, compared to those without, and that CHD risk varies greatly according to the extent of CAC both in persons with and without metabolic syndrome and diabetes mellitus. More recently, guidelines regarding the use of CAC screening have been extended to those with diabetes mellitus, helping to further stratify those patients that may benefit from more intensive therapy. This review evaluates the role and possible benefits of CAC screening, with a focus on those with metabolic syndrome and diabetes mellitus for evaluating the risk for CHD.
ACCESSION #
87564547

 

Related Articles

  • Impact of Reference Category and Number of Traits in the Cluster on Risk of Coronary Heart Disease in Metabolic Syndrome: Prospective Data from the Bruneck Study. Bonora, Enzo; Kiechl, Stefan; Zoppini, Giacomo; Targher, Giovanni; Meigs, James B.; Willeit, Johann; Oberhollenzer, Friedrich; Bonadonna, Riccardo C.; Muggeo, Michele // Metabolic Syndrome & Related Disorders;Aug2011, Vol. 9 Issue 4, p313 

    Background: We assessed the risk of coronary heart disease (CHD) in subjects with metabolic syndrome using different reference categories and focusing on the number of traits in the cluster. Methods: For 15 years, we followed 840 subjects from the general population living in Bruneck,...

  • The association between metabolic syndrome and coronary artery disease in Jordan. KHADER, YOUSEF S.; KHASAWNEH, BASHEER; DAOUD, AMMAR K.; KHATATBEH, MOAWIAH // Chronic Illness;Dec2009, Vol. 5 Issue 4, p235 

    Background: Previous studies in Jordan showed a considerably high prevalence of metabolic syndrome (MeS) and its individual components. However, data about the association between MeS and coronary artery disease (CAD) in Jordan are lacking. Therefore, this study aimed to determine the...

  • EISNER: CAC scanning associated with improved risk factors vs. no scanning.  // Cardiology Today;May2011, Vol. 14 Issue 5, p1 

    This article discusses a clinical trial involving patients with coronary artery disease risk factors who underwent coronary artery calcium scanning.

  • Community pharmacist assessment of 10-year risk of coronary heart disease for union workers and their dependents. Liu, Yifei; Mentele, Leslie J.; McDonough, Randal P.; Carruthers, Kara M.; Doucette, William R. // Journal of the American Pharmacists Association: JAPhA;Jul/Aug2008, Vol. 48 Issue 4, p515 

    Objective: To determine 10-year coronary heart disease (CHD) risk for union workers and their dependents in a pharmacist-managed health screening program. Methods: Two local unions of plumbers and electricians contracted with a community pharmacy to provide health screening services for union...

  • Spotting coronary risks among the healthy. Mackety, Carolyn Kramer // RN;Apr75, Vol. 38 Issue 4, p76 

    Discusses research being done on screening for patients at risk of coronary artery disease in a health population at the Swedish American Hospital in Rockford, Illinois. Start of the screening process; Description of the clinical setting; Role of nurses in the screening process.

  • THE RELATIONSHIP BETWEEN METABOLIC SYNDROME AND TARGET ORGAN DAMAGE IN GHANAIAN WITH STAGE-2 HYPERTENSION. BELLO-RODRIGUEZ, B. M.; SANCHEZ-CRUZ, G.; DELGADO-BUSTILLO, F.; ASIAMA, G. // Ghana Medical Journal;Dec2013, Vol. 47 Issue 4, p189 

    Objectives: To determine the frequency of Metabolic syndrome (MetS) in stage-2 hypertension and to assess the influence of MetS components over target organ damage (TOD) in Ghanaian patients. Methods: Forty adult patients with stage-2 hypertension were enrolled in a cross-sectional study...

  • The Relation Between Non-Alcoholic Fatty Liver Disease and the Risk of Coronary Heart Disease in Koreans. Choi, Su-Yeon; Kim, Donghee; Kim, Hwa Jung; Kang, Jin Hwa; Chung, Su Jin; Park, Min Jung; Kim, Young Sun; Kim, Chung Hyun; Choi, Seung Ho; Kim, Won; Kim, Yoon Jun; Yoon, Jung-Hwan; Lee, Hyo-Suk; Cho, Sang-Heon; Sung, Myung-Whun; Oh, Byung-Hee // American Journal of Gastroenterology (Springer Nature);Aug2009, Vol. 104 Issue 8, p1953 

    OBJECTIVES:Non-alcoholic fatty liver disease (NAFLD) is known to be related to factors that predict the development of coronary heart disease (CHD), such as dyslipidemia, central obesity, and metabolic syndrome (MS). The aim of this study was to determine whether individuals with NAFLD have an...

  • Estimation of the Long-term Cardiovascular Events Using UKPDS Risk Engine in Metabolic Syndrome Patients. SHIVAKUMAR, V.; KANDHARE, A. D.; RAJMANE, A. R.; ADIL, M.; GHOSH, P.; BADGUJAR, L. B.; SARAF, M. N.; BODHANKAR, S. L. // Indian Journal of Pharmaceutical Sciences;Mar/Apr2014, Vol. 76 Issue 2, p174 

    Long-term cardiovascular complications in metabolic syndrome are a major cause of mortality and morbidity in India and forecasted estimates in this domain of research are scarcely reported in the literature. The aim of present investigation is to estimate the cardiovascular events associated...

  • Prevalencia del síndrome metabólico en pacientes esquizofrénicos hospitalizados en Gran Canaria. Moreno, T. Sánchez-Araña; González, R. Touriño; Fleta, J. L. Hernández; Pérez, P. León // Actas Espanolas de Psiquiatria;nov2007, Vol. 35 Issue 6, p359 

    Introduction. Schizophrenic patients have a higher standardized mortality rate than that expected for the rest of the population. The prevalence of the metabolic syndrome is high among them, this increase coronary risk twofold to fourfold. This study aims to find out the prevalence of the...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics